Evidence map›Paper›PMID 39677369›Full record

ArticlePNAS nexus2024

Roles of the lamin A-specific tail region in the localization to sites of nuclear envelope rupture.

Yohei Kono, Chan-Gi Pack, Takehiko Ichikawa, Arata Komatsubara, Stephen A Adam, Keisuke Miyazawa, Loïc Rolas, Sussan Nourshargh, Ohad Medalia, Robert D Goldman and 3 more

Abstract read
In one paragraph

Article in PNAS nexus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. First Generation Proteolysis Targeting Chimeras (PROTACs) for the Treatment of Progeria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. The molecular basis of lamin-specific chromatin interactions.Nature structural & molecular biology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yohei KonoCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.ORCID https://orcid.org/0000-0001-8264-9417
Chan-Gi PackConvergence Medicine Research Center, Asan Institute for Life Science, Asan Medical Center, Seoul 05505, Korea.ORCID https://orcid.org/0000-0002-6578-3099
Takehiko IchikawaNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa 920-1192, Japan.ORCID https://orcid.org/0000-0002-2438-5502
Arata KomatsubaraSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8503, Japan.
Stephen A AdamDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 USA.ORCID https://orcid.org/0000-0003-3444-7655
Keisuke MiyazawaNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa 920-1192, Japan.ORCID https://orcid.org/0000-0002-5012-8040
Loïc RolasCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, United Kingdom.ORCID https://orcid.org/0000-0001-7617-0768
Sussan NoursharghCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, United Kingdom.ORCID https://orcid.org/0000-0001-5677-1806
Ohad MedaliaDepartment of Biochemistry, University of Zurich, Zurich 8057, Switzerland.ORCID https://orcid.org/0000-0003-0994-2937
Robert D GoldmanDepartment of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 USA.ORCID https://orcid.org/0000-0003-0383-1435
Takeshi FukumaNano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa 920-1192, Japan.ORCID https://orcid.org/0000-0001-8971-6002
Hiroshi KimuraCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.ORCID https://orcid.org/0000-0003-0854-083X
Takeshi ShimiCell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8503, Japan.ORCID https://orcid.org/0000-0002-9864-1820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nuclear lamina (NL) lines the nuclear envelope (NE) to maintain nuclear structure in metazoan cells. The major NL components, the nuclear lamins contribute to the protection against NE rupture induced by mechanical stress. Lamin A (LA) and a short form of the splicing variant lamin C (LC) are diffused from the nucleoplasm to sites of NE rupture in immortalized mouse embryonic fibroblasts (MEFs). LA localization to the rupture sites is significantly slow and weak compared with LC, but the underlying mechanism remains unknown. In this study, wild-type (WT), Hutchinson-Gilford Progeria syndrome (HGPS) knock-in MEFs expressing progerin (PG, an LA mutant lacking the second proteolytic cleavage site), and LA/C-knockout MEFs transiently and heterogeneously expressing LA/C WTs and mutants fused to mEmerald are examined before and after NE rupture induced by single-cell compression and laser microirradiation. The farnesylation at the CaaX motif of unprocessed LA and the inhibition of the second proteolytic cleavage decrease the nucleoplasmic pool and slow the localization to the rupture sites in a long-time window (60-70 min) after the induction of NE rupture. Our data could explain the defective repair of NE rupture in HGPS through the farnesylation at the CaaX motif of unprocessed progerin. In addition, unique segments in LA-specific tail region cooperate with each other to inhibit the rapid accumulation within a short-time window (3 min) that is also observed with LC.

Indexed as

HGPSlaminlaminanuclear envelope rupturenucleus

Identifiers

PMID39677369
PMCPMC11645434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.